Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies ; volume:2 ; number:2 ; day:9 ; month:7 ; year:2011 ; pages:197-212 ; date:8.2011
Clinical epigenetics ; 2, Heft 2 (9.7.2011), 197-212, 8.2011
- Urheber
-
Mascarenhas, John
- Beteiligte Personen und Organisationen
-
Roper, Nitin
Chaurasia, Pratima
Hoffman, Ronald
SpringerLink (Online service)
- DOI
-
10.1007/s13148-011-0050-6
- URN
-
urn:nbn:de:1111-2016072633813
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mascarenhas, John
- Roper, Nitin
- Chaurasia, Pratima
- Hoffman, Ronald
- SpringerLink (Online service)
Ähnliche Objekte (12)
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Myeloproliferative neoplasms: cause, mechanism and treatment
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Myeloproliferative neoplasms: cause, mechanism and treatment
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Targeted therapies for myeloproliferative neoplasms
Esophageal lesions in myeloproliferative neoplasms
Novel therapeutics in myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
New mouse models of myeloproliferative neoplasms
Myeloproliferative neoplasms : critical concepts and management
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms